title: Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines.
abstract: BACKGROUND
  T lymphocytes play a crucial role in the pathogenesis of inflammatory bowel disease. Achieving stable T-cell lines, rather than continuous bleeding of patients, is desirable in order to dissect their implication in the disease.
  
  
  METHODS
  Long-lasting T-cell lines from patients with Crohn disease and ulcerative colitis and from healthy volunteers have been obtained by transformation of T lymphocytes using the lymphotropic Herpesvirus saimiri. Lines were subjected to phenotypic and functional analyses, and the results compared with freshly isolated peripheral blood mononuclear cells.
  
  
  RESULTS
  Fresh cells revealed only minor differences between patients and controls, with regard to phenotype and proliferative capacity. In contrast, the use of T-cell lines showed that cells from Crohn disease patients, but not ulcerative colitis patients, over-responded to several membrane or cytoplasmic stimuli when compared to control T-cell lines. Thus, higher responses were found when stimulated with alphaCD3 and IL2, alphaCD3 and alphaCD28, IL2 alone, phorbol esters (PMA) and alphaCD3 and, finally, PMA and alphaCD2 (P < 0.05 in all instances). Further, lines from patients with Crohn disease responded more vigorously to alphaCD3 and alphaCD28 or alphaCD3 and PMA when compared to ulcerative colitis (P < 0.05 in both instances).
  
  
  CONCLUSIONS
  The data obtained with these lines suggest that T cells from patients with Crohn disease differ in vivo in their proliferative capacity, as compared with those from ulcerative colitis patients, a finding that may reflect the clear Th-1 phenotype found in the former and absent in the latter.
authors.affiliation: Inmunología, Facultad de Medicina, Universidad Complutense de Madrid, Spain.
authors.forename: N
authors.initials: N
authors.lastname: Aguilera-Montilla
authors.forename: M
authors.initials: M
authors.lastname: Pérez-Blas
authors.forename: A P
authors.initials: AP
authors.lastname: Valeri
authors.forename: M
authors.initials: M
authors.lastname: López-Santalla
authors.forename: C
authors.initials: C
authors.lastname: Rodríguez-Juan
authors.forename: A
authors.initials: A
authors.lastname: Mencía
authors.forename: G
authors.initials: G
authors.lastname: Castellano
authors.forename: M L
authors.initials: ML
authors.lastname: Manzano
authors.forename: B
authors.initials: B
authors.lastname: Casis
authors.forename: F
authors.initials: F
authors.lastname: Sánchez
authors.forename: J M
authors.initials: JM
authors.lastname: Martín-Villa
mesh_terms: D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000378:metabolism; D016022:Case-Control Studies; D002460:Cell Line; D049109:Cell Proliferation; D002472:Cell Transformation, Viral; D003093:Colitis, Ulcerative / Q000378:metabolism / Q000503:physiopathology*; D003424:Crohn Disease / Q000378:metabolism / Q000503:physiopathology*; D005260:Female; D006567:Herpesvirus 2, Saimiriine; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000502:physiology*
chemical_list: D015703:Antigens, CD